“…From the clinical deliverable (product) point of view, our work, as briefly reviewed above, has illustrated significant associations between genetic polymorphisms and immune response heterogeneity to live viral vaccines (Dhiman et al, 2007Poland et all, 2001;Ovsyannikova et al, 2004aOvsyannikova et al, , 2005aOvsyannikova et al, , 2008Sauver et al, 2002). Population-based immunogenetic studies inform and elucidate the mechanisms of protective immunity and provide a foundation for future vaccine development.…”